An epidemiological review of changes in meningococcal biology during the last 100 years

Pathogens and Global Health

Volumn 107, Issue 7, 2013, Pages 373-380

  Abio, Anne ^a,b   Neal, Keith R ^a   Beck, Charles R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GULU UNIVERSITY   (Uganda)

Author keywords

Epidemiology; Meningitis; Meningococcal; Neisseria meningitidis; Serogroups

Indexed keywords

AFRICA; BACTERIAL STRAIN; COCHRANE LIBRARY; EPIDEMIC; EPIDEMIOLOGICAL DATA; EUROPE; HIGH RISK POPULATION; HUMAN; MEDLINE; MENINGOCOCCOSIS; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; PUBLIC HEALTH SERVICE; REVIEW; SCIENTIFIC LITERATURE; SOUTH AMERICA; VACCINATION; WAR;

EPIDEMIOLOGY; MENINGITIS,; MENINGOCOCCAL,; NEISSERIA MENINGITIDIS,; SEROGROUPS,;

AFRICA; EUROPE; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; PHYLOGENY; SOUTH AMERICA;

EID: 84892752427     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773213Y.0000000119     Document Type: Review

References (78)

1. Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004;23:S274-9.
2. Al-Tawfiq JA, Clark TA, Memish ZA. Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology. J Travel Med. 2010;17:3-8.
3. Cartwright K, Noah N, Peltola H, Meningococcal Disease Advisory Board. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine. 2001;19:4347-56.
4. Safadi MA, Barros AP. Meningococcal conjugate vaccines: efficacy and new combinations. J Pediatr (Rio J). 2006;82: S35-44.
5. Frosch M, Maiden MCJ. Handbook of meningococcal disease: infection biology, vaccination, clinical management. Weinheim, Germany: Wiley-VCH; 2006.
6. Safadi MAP, McIntosh EDG. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies. Expert Rev Vaccines. 2011;10:1717-30.
7. Leimkugel J, Racloz V, Jacintho da Silva L, Pluschke G. Global review of meningococcal disease. A shifting etiology. J Bacteriol Res. 2009;1:6-18.
8. Dudley SF, Brennan JR. High and persistent carrier rates of Neisseria meningitidis, unaccompanied by cases of Meningitis. J Hyg. 1934;34:525-41.
9. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Medical progress: Meningococcal disease. N Engl J Med. 2001;344:1378-88.
10. Ibarz-Pavón AB, MacLennan J, Andrews NJ, Gray SJ, Urwin R, Clarke SC. Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J. Infect. Dis. 2011;204:1046-53.
11. Kristiansen AP, Diomandé F, Wei CS, Ouédraogo R, Sangaré L, Sanou I. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine. Clin Vaccine Immunol. 2011;18:435-43.
12. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;2:B51-63.
13. Morley SL, Pollard AJ. Vaccine prevention of meningococcal disease, coming soon? Vaccine. 2001;20:666-87.
14. Safadi MAP, Cintra OAL. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol Res. 2010;32:263-71.
15. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines. 2010;9:285-98.
16. World Health Organization. Meningococcal meningitis. Geneva: World Health Organization; 2003.
17. Panatto D, Amicizia D, Lai PL, Gasparini R. Neisseria meningitidis B vaccines. Expert Rev Vaccines. 2011;10:1337-51.
18. World Health Organization. Emergence of W135 meningococcal disease. Geneva: World Health Organization; 2001.
19. Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012;30:B26-B36.
20. Fairbrother RW. Meningococcal meningitis with particular reference to epidemiology and pathogenesis. J Clin Pathol. 1947;1:10-8.
21. Arkwright JA. Grouping of the strains of meningococcus: isolated during the epidemic of cerebrospinal meningitis in 1915. Br Med J. 1915;2:885-8.
22. Houston T, Rankin JC. Cerebro-spinal fever and meningococci infection. Ulster Med J. 1940;9:61-6.
23. Pringle AM. The epidemiology of meningococcal meningitis, or cerebro-spinal fever. BMJ. 1918;1:398.
24. Kriz P, Wieffer H, Holl K, Rosenlund M, Budhia S, Vyse A. Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century. Expert Rev Vaccines. 2011;10:1477-86.
25. Schwartz B, Moore PS, Broome CV. Global epidemiology of meningococcal disease. Clin Microbiol Rev. 1989;2:S118-S24.
26. Grahlow WD, Ocklitz HW, Mochmann H. Meningococcal infections in the German Democratic Republic 1971-1984. Infection. 1986;14:286-8.
27. Stanton MC, Taylor-Robinson D, Harris D, et al. Meningococcal disease in children in Merseyside, England: a 31 year descriptive study. PLoS One. 2011;6:e25957.
28. Berild D, Gedde-Dahl TW, Abrahamsen T. Meningococcal disease in the Norwegian Armed Forces 1967-1979. Some epidemiological aspects. NIPH Ann. 1980;3:23-30.
29. Iversen BG, Aavitsland P. Meningococcal disease in Norway 1992-1995. Epidemiology and fatality. Scand J Infect Dis. 1996;28:253-9.
30. Bovre K, Gedde-Dahl TW. Epidemiological patterns of meningococcal disease in Norway 1975-1979. NIPH Ann. 1980;3:9-22.
31. Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975-91. NIPH Ann. 1991;14:57-65; discussion-6.
32. Olivares R, Hubert B. Clusters of meningococcal disease in France (1987-1988). Eur J Epidemiol. 1992;8:737-42.
33. Demina AA, Pokrovskij VI, Iljina TI, Larina LI, Devjakina NP. Surveillance of meningococcal infections and other forms of purulent meningitis: a 4-year study in the USSR. Bull World Health Organ. 1986;64:263-9.
34. Connolly M, Noah N. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group. Epidemiol Infect. 1999;122:41-9.
35. Tsolia MN, Theodoridou M, Tzanakaki G, Kalabalikis P, Urani E, Mostrou G, et al. The evolving epidemiology of invasive meningococcal disease: a two-year prospective, population-based study in children in the area of Athens. FEMS Immunol Med Microbiol. 2003;36:87-94.
36. Tzanakaki G, Blackwell CC, Kremastinou J, Weir DM, Mentis A, Fallon RJ. Serogroups, serotypes and subtypes of Neisseria meningitidis isolated from patients and carriers in Greece. J Med Microbiol. 1993;38:19-22.
37. Pavlopoulou ID, Daikos GL, Alexandrou H, Petridou E, Pangalis A, Theodoridou M, et al. Carriage of Neisseria meningitidis by Greek children: risk factors and strain characteristics. Clin Microbiol Infect. 2004;10:137-42.
38. Wylie PAL, Stevens D, Drake W, Stuart J, Cartwright K. Epidemiology and clinical management of meningococcal disease in West Gloucestershire: retrospective, population based study. BMJ. 1997;315:774-9.
39. Meningococcal Reference Unit, Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol. 2006;55:887-96.
40. Shigematsu M, Davison KL, Charlett A, Crowcroft NS. National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001. Epidemiol Infect. 2002;129:459-70.
41. Kafetzis DA, Stamboulidis KN, Tzanakaki G, Kourea Kremastinou J, Skevaki CL, Konstantopoulos A, et al. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Clin Microbiol Infect. 2007;13:550-2.
42. ECDC. Annual epidemiological report 2011. Stockholm: European Centre for Disease Prevention and Control; 2011.
43. Ladhani SN, Flood JS, Ramsay ME, Campbell H, Gray SJ, Kaczmarski EB, et al. Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines. Vaccine. 2012;30:3710-6.
44. Perrocheau A, Taha MK, Levy-Bruhl D. Epidemiology of invasive meningococcal disease in France in 2003. Euro Surveill. 2005;10:238-41.
45. Safadi MA, Gonzalez-Ayala S, Jakel A, Wieffer H, Moreno C, Vyse A. The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape. Epidemiol Infect. 2012:1-12.
46. De Gaspari E, Zollinger W. Expression of class 5 antigens by meningococcal strains obtained from patients in Brazil and evaluation of two new monoclonal antibodies. Braz J Infect Dis. 2001;5:143-53.
47. Puricelli RCB, Kupek E, Westrupp MHB. Three decades of meningococcal disease in the state of Santa Catarina, Brazil. Braz J Infect Dis. 2004;8:241-8.
48. de Cassia Campos Bertoncini R, Andre Herberts R, Goulart Dario M, Roberto Merlin C, Miletti LC. Epidemiological study of Neisseria meningitidis strains isolated from cases of meningococcal disease in Santa Catarina State, Brazil, 1987-2003. Public Health. 2007; 121: 880-3.
49. Barroso DE, Carvalho DM, Casagrande ST, Rebelo MC, Soares V, Zahner V, et al. Microbiological epidemiological history of meningococcal disease in Rio de Janeiro, Brazil. Braz J Infect Dis. 2010;14:242-51.
50. Baethgen LF, Weidlich L, Moraes C, Klein C, Nunes LS, Cafrune PI, et al. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing. Trop Med Int Health. 2008;13:31-40.
51. Cordeiro SM, Neves AB, Ribeiro CT, Petersen ML, Gouveia EL, Ribeiro GS, et al. Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil. Trans R Soc Trop Med Hyg. 2007;101:1147-53.
52. Iser BP, Lima HC, de Moraes C, de Almeida RP, Watanabe LT, Alves SL, et al. Outbreak of Neisseria meningitidis C in workers at a large food-processing plant in Brazil: challenges of controlling disease spread to the larger community. Epidemiol Infect. 2012;140:906-15.
53. Hollis DG, Wiggins GL, Weaver RE. Neisseria lactamicus sp. n., a lactose-fermenting species resembling Neisseria meningitidis. Appl Microbiol. 1969;17:71-7.
54. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and metaanalysis. Lancet Infect Dis. 2010;10:853-61.
55. MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, et al. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006;12:950-7.
56. Jolley KA, Kalmusova J, Feil EJ, Gupta S, Musilek M, Kriz P, et al. Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol. 2000;38:4492-8.
57. Glitza IC, Ehrhard I, Mueller-Pebody B, Reintjes R, Breuer T, Ammon A, et al. Longitudinal study of meningococcal carrier rates in teenagers. Int J Hyg Environ Health. 2008;211:263-72.
58. Neal KR, Nguyen-Van-Tam JS, Jeffrey N, Slack RC, Madeley RJ, Ait-Tahar K, et al. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ. 2000;320:846-9.
59. Blackwell CC, Tzanakaki G, Kremastinou J, Weir DM, Vakalis N, Elton RA, et al. Factors affecting carriage of Neisseria meningitidis among Greek military recruits. Epidemiol Infect. 1992;108:441-8.
60. Caugant DA, Hoiby EA, Magnus P, Scheel O, Hoel T, Bjune G, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32:323-30.
61. Cartwright KAV, Stuart JM, Jones DM, Noah ND. The stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect. 1987;99:591-601.
62. Soriano-Gabarro M, Wolter J, Hogea C, Vyse A. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Expert Rev Anti Infect Ther. 2011;9:761-74.
63. Kriz P, Kriz B, Svandova E, Musilek M. Antimeningococcal herd immunity in the Czech Republic-influence of an emerging clone, Neisseria meningitidis ET-15/37. Epidemiol Infect. 1999;123:193-200.
64. Kremastinou J, Tzanakaki G, Velonakis E, Voyiatzi A, Nickolaou A, Elton RA, et al. Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek school children from Russian immigrant families in Athens. FEMS Immunol Med Microbiol. 1999;23:13-20.
65. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, et al. Genetic analysis of meningococci carried by children and young adults. J Infect Dis. 2005;191:1263-71.
66. Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev. 2007;31:52-63.
67. Bevanger L, Bergh K, Gisnas G, Caugant DA, Froholm LO. Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods. J Med Microbiol. 1998; 47:993-8.
68. Cartwright KAV, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiology Infect. 1987;99:591-601.
69. MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, et al. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006;12:950-7.
70. Barroso DE, Rebelo MC. Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil. Mem Inst Oswaldo Cruz. 2007;102:773-5.
71. World Health Organization. Control of epidemic meningococcal disease. WHO practical guidelines. 2nd edn. Geneva: World Health Organization; 1998.
72. Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, et al. A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev. 2007;31:27-36.
73. Bose A, Coen P, Tully J, Viner R, Booy R. Effectiveness of meningococcal C conjugate vaccine in teenagers in England. Lancet. 2003;361:675-6.
74. Maiden MC, Stuart JM, UK Meningococcal Carriage Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet. 2002;359: 1829-30.
75. Glover JA. Observations on the meningococcus carrier-rate in relation to density of population in sleeping quarters. J Hyg. 1918;17:367-79.
76. Chang Q, Tzeng Y-L, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol. 2012:237-45.
77. Daugla D, Gami J, Gamougam K, Naibei N, Mbainadji L, Narbé M, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial. Lancet. 2013; pii: S0140-6736(13)61612-8.
78. Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone, G et al. Immunogenicity and safety of a meningococcal a conjugate vaccine in Africans. N Engl J Med. 2011;364:2293-3304.